Managers’ transactions announcement according to article 19 MAR
Heidelberg (pta047/05.10.2020/16:17) - Announcement
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |
| a) | Name | Dr Trevor Jarman |
| 2 | Reason for the notification | |
| a) | Position/status | Member of the administrative or supervisory body |
| b) | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| a) | Name | 4basebio AG |
| b) | LEI | 391200H5BDEVHMOV3U10 |
| 4 | Details of the transaction(s) | |
| a) | Description of the financial instrument, type of instrument | Share |
| Identification code | DE000A2YN801 | |
| b) | Nature of the transaction | Sale |
| c) | Price(s) | Volume(s) |
| 2.00 EUR | 640,000.00 EUR | |
| d) | Aggregated price | Aggregated volume |
| 2.00 EUR | 640,000.00 EUR | |
| e) | Date of the transaction | 30.09.2020 UTC+2 |
| f) | Place of the transaction | Outside a trading venue |
| 5 | Explanation | |
| Verkauf im Rahmen des Ãœbernahmeangebots der Sparta AG. | ||
| (end) | ||
emitter: 4basebio AG
address: Waldhofer Str. 102, 69123 Heidelberg
country: Germany
contact person: Robert Mayer
phone: +49 171 3876540
e-mail: [email protected]
website: investors.4basebio.com
ISIN(s): DE000A2YN801 (share)
stock exchanges: regulated market in Frankfurt; free market in Stuttgart, free market in Munich, free market in Hamburg, free market in Dusseldorf; open market in Berlin, Tradegate